Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

BACKGROUND & AIMS Although inflammation is presumed to contribute to colonic neoplasia in ulcerative colitis (UC), few studies have directly examined this relationship. Our aim was to determine whether severity of microscopic inflammation over time is an independent risk factor for neoplastic progression in UC. METHODS A cohort of patients with UC undergoing regular endoscopic surveillance for dysplasia was studied. Degree of inflammation at each biopsy site had been graded as part of routine clinical care using a highly reproducible histologic activity index. Progression to neoplasia was analyzed in proportional hazards models with inflammation summarized in 3 different ways and each included as a time-changing covariate: (1) mean inflammatory score (IS-mean), (2) binary inflammatory score (IS-bin), and (3) maximum inflammatory score (IS-max). Potential confounders were analyzed in univariate testing and, when significant, in a multivariable model. RESULTS Of 418 patients who met inclusion criteria, 15 progressed to advanced neoplasia (high-grade dysplasia or colorectal cancer), and 65 progressed to any neoplasia (low-grade dysplasia, high-grade dysplasia, or colorectal cancer). Univariate analysis demonstrated significant relationships between histologic inflammation over time and progression to advanced neoplasia (hazard ration (HR), 3.0; 95% CI: 1.4-6.3 for IS-mean; HR, 3.4; 95% CI: 1.1-10.4 for IS-bin; and HR, 2.2; 95% CI: 1.2-4.2 for IS-max). This association was maintained in multivariable proportional hazards analysis. CONCLUSIONS The severity of microscopic inflammation over time is an independent risk factor for developing advanced colorectal neoplasia among patients with long-standing UC.

[1]  A. Zinsmeister,et al.  Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. , 2006, Gastroenterology.

[2]  D. Present,et al.  Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. , 2005, Inflammatory bowel diseases.

[3]  K. Geboes.  Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ? , 2004, Acta gastro-enterologica Belgica.

[4]  S. Itzkowitz,et al.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[5]  Noam Harpaz,et al.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. , 2004, Gastroenterology.

[6]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[7]  Noam Harpaz,et al.  Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. , 2003, Gastroenterology.

[8]  Yunni-Yi Chen,et al.  Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis , 2003, Inflammatory bowel diseases.

[9]  T. Ullman.  Patients with low-grade dysplasia should be advised to undergo colectomy. , 2003, Inflammatory bowel diseases.

[10]  N. Harpaz,et al.  Histological grading of disease activity in chronic IBD Inter- and intra-observer variation among pathologists with different levels of experience , 2003 .

[11]  L. Sutherland,et al.  Assessing disease activity and disease activity indices for inflammatory bowel disease , 2002, Current gastroenterology reports.

[12]  S. Kakar,et al.  The fate of low grade dysplasia in ulcerative colitis , 2002, American Journal of Gastroenterology.

[13]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[14]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[15]  A. Öst,et al.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.

[16]  J. Mayberry,et al.  How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. , 2000, Gastrointestinal endoscopy.

[17]  K. Abrams,et al.  Colorectal cancer prevention in ulcerative colitis: a case‐control study , 2000, Alimentary pharmacology & therapeutics.

[18]  N. Harpaz,et al.  Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. , 1999, Gastroenterology.

[19]  R. Odze,et al.  Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. , 1999, Gastroenterology.

[20]  J. Wong,et al.  Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis , 1998, American Journal of Gastroenterology.

[21]  D. Levine,et al.  Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. , 1995, The American journal of gastroenterology.

[22]  A. MacDonald.  Modelling Survival Data in Medical Research. By D. Collett (Chapman & Hall, 1994) £19.99 , 1995, British Actuarial Journal.

[23]  D. Collet.  Modelling Survival Data in Medical Research , 2004 .

[24]  David Collett.  Modelling Survival Data in Medical Research , 1994 .

[25]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[26]  H. Adami,et al.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. , 1994, Gastroenterology.

[27]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[28]  A. Axon,et al.  Failure of colonoscopic surveillance in ulcerative colitis. , 1993, Gut.

[29]  B. Korelitz,et al.  Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. , 1992, Gastroenterology.

[30]  A. Ekbom.  Ulcerative Colitis and Colorectal Cancer , 1991 .

[31]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[32]  J. Jass,et al.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. , 1989, Human pathology.

[33]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[34]  K. White,et al.  Clinical epidemiology. , 1983, International journal of epidemiology.

[35]  D.,et al.  Regression Models and Life-Tables , 2022 .